INOVIO is focused on rapidly bringing to market precisely designed and delivered DNA medicines to potentially treat and protect people from a range of serious and life-threatening diseases related to HPV, cancer, and infectious diseases.
INOVIO’s first-of-their-kind DNA medicines are precisely designed DNA plasmids delivered through INOVIO’s unique smart device directly into the body’s cells to produce an immune response robust enough to potentially treat and prevent disease.
The advantages of INOVIO’s DNA medicine platform are how fast DNA medicines can be designed and manufactured; the stability of the products, which do not require freezing in storage and transport; and the robust immune response and tolerability that have been demonstrated in clinical trials.
With more than 2,000 patients receiving INOVIO DNA medicines in more than 7,000 applications across a range of clinical trials, INOVIO has a strong track record of rapidly generating DNA medicine candidates to meet urgent health needs.
© Copyright 2020 INOVIO Pharmaceuticals. All rights reserved.